Proliferator-activated receptor gamma co-activator (PGC)-1α and mitochondrial transcription factor A (TFAM) are overexpressed in cisplatin-resistant ovarian cancer; similarly, PGC-1β confers the chemoresistance of lung cancer cells to cisplatin associated with mtDNA mutations (77, 78). This evidence concerns the gene TFAM and ovarian cancer.